FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
作者信息
Kliem V, Eberhard O K, Oldhafer K, Schlitt H J, Behrend M, Schaumann D, Pichlmayr R, Koch K M, Brunkhorst R
机构信息
Abteilung Nephrologie, Medizinische Hochschule Hannover, Germany.
出版信息
Transplant Proc. 1996 Dec;28(6):3166-8.
PMID:8962227
Abstract
摘要
相似文献
1
2
3
Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.OKT3对肾移植患者类固醇抵抗性急性排斥反应的长期疗效。
Transplant Proc. 1996 Jun;28(3):1354-5.
4
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.肝移植受者在使用OKT3之前用他克莫司治疗类固醇抵抗性排斥反应。
Transplant Proc. 1996 Apr;28(2):1014.
5
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.协议活检在使用FK 506治疗难治性肾移植排斥反应中的作用。
Transplant Proc. 1996 Apr;28(2):998-9.
6
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Transplant Proc. 1993 Aug;25(4):2693-4.
7
Long-term results of OKT3-treated renal transplant recipients.
Transplant Proc. 1996 Jun;28(3):1350-1.
8
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.OKT3与FK 506对急性类固醇抵抗和慢性排斥反应的挽救性管理
Transplant Proc. 1995 Feb;27(1):1111-3.
9
OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.除他克莫司外，OKT3治疗与激素难治性肾移植排斥患者的长期功能改善相关。
Nephron Clin Pract. 2006;103(3):c94-9. doi: 10.1159/000092017. Epub 2006 Mar 13.
10
Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.
Transplant Proc. 1997 Nov;29(7):2955-7. doi: 10.1016/s0041-1345(97)00743-4.
引用本文的文献
1
Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.霉酚酸酯的胃肠道不良反应：病因、发生率及处理
Drug Saf. 2001;24(9):645-63. doi: 10.2165/00002018-200124090-00002.
Zotero 插件